Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta for cancer-related fatigue
NCT00376675Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate osmotic release oral system in cancer-related fatigue (CRF), sponsored by Cancer and Leukemia Group B. Started Feb 2008; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00376675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376675.